https://pipelinereview.com/Novartis-lung-cancer-drug-Zykadia-recommended-for-EU-approval-in-patients-with-ALK-NSCLC-previously-treated-with-crizotinib/
Novartis lung cancer drug Zykadia® recommended for EU approval in patients with ALK+ NSCLC previously treated with crizotinib